Retinal ion regulation in a mouse model of diabetic retinopathy: Natural history and the effect of Cu/Zn superoxide dismutase overexpression

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 5, 2009, Pages 2351-2358

  Berkowitz, Bruce A ^a,b   Gradianu, Marius ^a   Bissig, David ^a   Kern, Timothy S ^c   Roberts, Robin ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; GLYCOSYLATED HEMOGLOBIN; MANGANESE; ION CHANNEL; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; DARK ADAPTATION; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE DURATION; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; ION TRANSPORT; LIGHT ADAPTATION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETINA; RETINA BLOOD VESSEL; SENSITIVITY ANALYSIS; THICKNESS; VISION; WILD TYPE; ACTIVE TRANSPORT; ANIMAL; C57BL MOUSE; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENETICS; LIGHT; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; DARK ADAPTATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; ION CHANNELS; ION TRANSPORT; LIGHT; MAGNETIC RESONANCE IMAGING; MALE; MANGANESE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RETINA; SUPEROXIDE DISMUTASE;

EID: 65549157077     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2918     Document Type: Article

References (60)

1. Grunwald JE, Riva CE, Brucker AJ, Sinclair SH, Petrig BL. Altered retinal vascular response to 100% oxygen breathing in diabetes mellitus. Ophthalmology. 1984;91(12):1447-1452.
2. Sinclair SH, Grunwald JE, Riva CE, Braunstein SN, Nichols CW, Schwartz SS. Retinal vascular autoregulation in diabetes mellitus. Ophthalmology. 1982;89(7):748-750.
3. Trick GL, Berkowitz BA. Retinal oxygenation response and retinopathy. Prog Retin Eye Res. 2005;24(2):259-274.
4. Phipps JA, Fletcher EL, Vingrys AJ. Paired-flash identification of rod and cone dysfunction in the diabetic rat. Invest Ophthalmol Vis Sci. 2004;45(12):4592-4600.
5. Han Y, Bearse MA Jr, Schneck ME, Barez S, Jacobsen CH, Adams AJ. Multifocal electroretinogram delays predict sites of subsequent diabetic retinopathy. Invest Ophthalmol Vis Sci. 2004;45(3):948-954.
6. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes: early onset and effect of insulin. J Clin Invest. 1998;102(4):783-791.
7. Schaefer S, Kajimura M, Tsuyama S, et al. Aberrant utilization of nitric oxide and regulation of soluble guanylate cyclase in rat diabetic retinopathy. Antioxid Redox Signal. 2003;5(4):457-465.
8. Barber AJ, Antonetti DA, Kern TS, et al. The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci. 2005;46(6):2210-2218.
9. Barber AJ. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(2):283-290.
10. Budzynski E, Wangsa-Wirawan N, Padnick-Silver L, Hatchell D, Linsenmeier R. Intraretinal pH in diabetic cats. Curr Eye Res. 2005;30(3):229-240.
11. Ottlecz A, Bensaoula T, Eichberg J, Peterson RG. Angiotensin-converting enzyme activity in retinas of streptozotocin-induced and Zucker diabetic rats: the effect of angiotensin II on Na+,K(+)-ATPase activity. Invest Ophthalmol Vis Sci. 1996;37(11):2157-2164.
12. Kern TS, Kowluru RA, Engerman RL. Abnormalities of retinal metabolism in diabetes or galactosemia: ATPases and glutathione. Invest Ophthalmol Vis Sci. 1994;35(7):2962-2967.
13. Ottlecz A, Garcia CA, Eichberg J, Fox DA. Alterations in retinal Na+, K(+)-ATPase in diabetes: streptozotocin-induced and Zucker diabetic fatty rats. Curr Eye Res. 1993;12(12):1111-1121.
14. MacGregor LC, Matschinsky FM. Altered retinal metabolism in diabetes, II: measurement of sodium-potassium ATPase and total sodium and potassium in individual retinal layers. J Biol Chem. 1986;261(9):4052-4058.
15. Zhang P, Hatter A, Liu B. Manganese chloride stimulates rat microglia to release hydrogen peroxide. Toxicol Lett. 2007;173(2):88-100.
16. Di Leo MA, Santini SA, Cercone S, et al. Chronic taurine supplementation ameliorates oxidative stress and Na K ATPase impairment in the retina of diabetic rats. Amino Acids. 2002;23(4):401-406.
17. Berkowitz BA, Roberts R, Stemmler A, Luan H, Gradianu M. Impaired apparent ion demand in experimental diabetic retinopathy: correction by lipoic acid. Invest Ophthalmol Vis Sci. 2007;48(10): 4753-4758.
18. Ottlecz A, Bensaoula T. Captopril ameliorates the decreased Na+,K(+)-ATPase activity in the retina of streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci. 1996;37(8):1633-1641.
19. Zhang JZ, Xi X, Gao L, Kern TS. Captopril inhibits capillary degeneration in the early stages of diabetic retinopathy. Curr Eye Res. 2007;32(10):883-889.
20. Kowluru RA, Atasi L, Ho YS. Role of mitochondrial superoxide dismutase in the development of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2006;47(4):1594-1599.
21. Sadi G, Yilmaz O, Guray T. Effect of vitamin C and lipoic acid on streptozotocin-induced diabetes gene expression: mRNA and protein expressions of Cu-Zn SOD and catalase. Mol Cell Biochem. 2008;309(1-2):109-116.
22. Kanwar M, Chan PS, Kern TS, Kowluru RA. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest Ophthalmol Vis Sci. 2007 48(8): 3805-3811.
23. Kowluru RA, Kowluru V, Xiong Y, Ho YS. Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress. Free Radic Biol Med. 2006; 41(8):1191-1196.
24. Marklund SL. Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem J. 1984;222(3):649-655.
25. Behndig A, Svensson B, Marklund SL, Karlsson K. Superoxide dismutase isoenzymes in the human eye. Invest Ophthalmol Vis Sci. 1998;39(3):471-475.
26. Okado-Matsumoto A, Fridovich I. Subcellular distribution of superoxide dismutases (SOD) in rat liver. Cu,Zn-SOD in mitochondria. J Biol Chem. 2001;276(42):38388-38393.
27. Levkovitch-Verbin H, Harris-Cerruti C, Groner Y, Wheeler LA, Schwartz M, Yoles E. RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotection. Invest Ophthalmol Vis Sci. 2000;41(13):4169-4174.
28. Klaeger C, de Sa L, Klaeger AJ, Carlson EJ, Good WV, Epstein CJ. An elevated level of copper zinc superoxide dismutase fails to prevent oxygen induced retinopathy in mice. Br J Ophthalmol. 1996;80(5):429-434.
29. Dong A, Shen J, Krause M, et al. Superoxide dismutase 1 protects retinal cells from oxidative damage. J Cell Physiol. 2006;208(3): 516-526.
30. Kowluru RA, Kern TS, Engerman RL. Abnormalities of retinal metabolism in diabetes or experimental galactosemia, IV: antioxidant defense system. Free Radic Biol Med. 1997;22(4):587-592.
31. Kowluru RA, Kern TS, Engerman RL, Armstrong D. Abnormalities of retinal metabolism in diabetes or experimental galactosemia, III: effects of antioxidants. Diabetes. 1996;45(9):1233-1237.
32. Kowluru R. Retinal metabolic abnormalities in diabetic mouse: comparison with diabetic rat. Curr Eye Res. 2002;24(2):123-128.
33. Lin YJ, Koretsky AP. Manganese ion enhances T1-weighted MRI during brain activation: an approach to direct imaging of brain function. Magn Reson Med. 1997;38(3):378-388.
34. Yu X, Wadghiri YZ, Sanes DH, Turnbull DH. In vivo auditory brain mapping in mice with Mn-enhanced MRI. Nat Neurosci. 2005;8(7): 961-968.
35. Berkowitz BA, Roberts R, Luan H, et al. Manganese-enhanced MRI studies of alterations of intraretinal ion demand in models of ocular injury. Invest Ophthalmol Vis Sci. 2007;48(8):3796-3804.
36. Berkowitz BA, Roberts R, Penn JS, Gradianu M. High-resolution manganese-enhanced MRI of experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2007;48(10):4733-4740.
37. Braun RD, Gradianu M, Vistisen KS, Roberts RL, Berkowitz BA. Manganese-enhanced MRI of human choroidal melanoma xenografts. Invest Ophthalmol Vis Sci. 2007;48(3):963-967.
38. Wendland MF. Applications of manganese-enhanced magnetic resonance imaging (MEMRI) to imaging of the heart. NMR Biomed. 2004;17(8):581-594.
39. Berkowitz BA, Roberts R, Goebel DJ, Luan H. Noninvasive and simultaneous imaging of layer-specific retinal functional adaptation by manganese-enhanced MRI. Invest Ophthalmol Vis Sci. 2006; 47(6):2668-2674.
40. Lu H, Xi ZX, Gitajn L, Rea W, Yang Y, Stein EA. Cocaine-induced brain activation detected by dynamic manganese-enhanced magnetic resonance imaging (MEMRI). Proc Natl Acad Sci U S A. 2007;104(7):2489-2494.
41. Craven PA, Melhem MF, Phillips SL, DeRubertis FR. Overexpression of Cu2 /Zn2 superoxide dismutase protects against early diabetic glomerular injury in transgenic mice. Diabetes. 2001; 50(9):2114-2125.
42. Epstein CJ, Avraham KB, Lovett M, et al. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. Proc Natl Acad Sci U S A. 1987;84(22):8044-8048.
43. Schupp DG, Merkle H, Ellermann JM, Ke Y, Garwood M. Localized detection of glioma glycolysis using edited 1H MRS. Magn Reson Med. 1993;30(1):18-27.
44. Kern TS, Engerman RL. Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin. Diabetes. 2001 50(7): 1636-1642.
45. Zheng L, Szabo C, Kern TS. Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-B. Diabetes. 2004 53(11):2960-2967.
46. 2 mapping. Invest Ophthalmol Vis Sci. 1996;37(10):2089-2098.
47. Cheng H, Nair G, Walker TA, et al. Structural and functional MRI reveals multiple retinal layers. Proc Natl Acad Sci U S A. 2006; 103(46):17525-17530.
48. Liang Z. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
49. Silva AC, Lee JH, Aoki I, Koretsky AP. Manganese-enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations. NMR Biomed. 2004;17(8):532-543.
50. Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB. Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci. 2004;45(9):3330-3336.
51. Zhou X, Xie J, Shen M, et al. Biometric measurement of the mouse eye using optical coherence tomography with focal plane advancement. Vision Res. 2008;48(9):1137-1143.
52. Remtulla S, Hallett PE. A schematic eye for the mouse, and comparisons with the rat. Vision Res. 1985;25(1):21-31.
53. Berkowitz BA, Gradianu M, Schafer S, et al. Ionic dysregulatory phenotyping of pathologic retinal thinning with manganese-enhanced MRI. Invest Ophthalmol Vis Sci. 2008;49:3178-3184.
54. Cooper GJS, Chan YK, Dissanayake AM, et al. Demonstration of a hyperglycemia-driven pathogenic abnormality of copper homeostasis in diabetes and its reversibility by selective chelation: quantitative comparisons between the biology of copper and eight other nutritionally essential elements in normal and diabetic individuals. Diabetes. 2005;54(5):1468-1476.
55. Walter RM Jr, Uriu-Hare JY, Olin KL, et al. Copper, zinc, manganese, and magnesium status and complications of diabetes mellitus. Diabetes Care. 1991;14(11):1050-1056.
56. Failla ML, Kiser RA. Altered tissue content and cytosol distribution of trace metals in experimental diabetes. J Nutr. 1981;111(11): 1900-1909.
57. Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham M, Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res. 2004;23(1):91-147.
58. Kowluru RA, Kanwar M, Kennedy A. Metabolic memory phenomenon and accumulation of peroxynitrite in retinal capillaries. Exp Diabetes Res. 2007;2007:21976.
59. Kern TS, Engerman RL. A mouse model of diabetic retinopathy. Arch Ophthalmol. 1996;114(8):986-990.
60. DeRubertis FR, Craven PA, Melhem MF, Salah EM. Attenuation of renal injury in db/db mice overexpressing superoxide dismutase: evidence for reduced superoxide-nitric oxide interaction. Diabetes. 2004;53(3):762-768.